CLINICAL_TRIALS
research
· 2025-02-21
Clinical Trial Update: Safety and Tolerability of VGB-R04 in Patients With Haemophilia B [EARLY_Phase 1]
Summary
An early-phase, safety and tolerability study of VGB-R04 in Hemophilia B is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Hemophilia B | EARLY_Phase 1 | Status: RECRUITING